BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9440305)

  • 1. Modelling the control of ovulation and polycystic ovary syndrome.
    Chávez-Ross A; Franks S; Mason HD; Hardy K; Stark J
    J Math Biol; 1997 Nov; 36(1):95-118. PubMed ID: 9440305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling endocrine control of the pituitary-ovarian axis: androgenic influence and chaotic dynamics.
    Hendrix AO; Hughes CL; Selgrade JF
    Bull Math Biol; 2014 Jan; 76(1):136-56. PubMed ID: 24272388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mechanism for Ovulation Number Control.
    Shilo M; Mayo A; Alon U
    Front Endocrinol (Lausanne); 2022; 13():816967. PubMed ID: 35909517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation and the polycystic ovary syndrome.
    Jansen RP
    Aust N Z J Obstet Gynaecol; 1994 Jun; 34(3):277-85. PubMed ID: 7848200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-scale modeling of the follicle selection process in the ovary.
    Echenim N; Monniaux D; Sorine M; Clément F
    Math Biosci; 2005 Nov; 198(1):57-79. PubMed ID: 16038949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular dynamics in the polycystic ovary syndrome.
    Franks S; Mason H; Willis D
    Mol Cell Endocrinol; 2000 May; 163(1-2):49-52. PubMed ID: 10963873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of counting follicles in diagnosis of polycystic ovary syndrome by the three-dimensional ultrasound imaging with sonography based automated volume calculation method].
    He LR; Zhou LX; Pan RK; Zhang X
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):350-4. PubMed ID: 21733371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiology of the menstrual cycle].
    Pricop M
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):347-61. PubMed ID: 3937195
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.
    Polson DW; Kiddy DS; Mason HD; Franks S
    Fertil Steril; 1989 Jan; 51(1):30-4. PubMed ID: 2491994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The central stimuli for follicular ripening and ovulation].
    Buchholz R
    Arch Gynakol; 1969; 207(1):107-23. PubMed ID: 4895931
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.
    Palomba S; Falbo A; Russo T; Orio F; Tolino A; Zullo F
    Hum Reprod; 2010 Apr; 25(4):1005-13. PubMed ID: 20106839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome?
    Carmina E; Longo A; Lobo RA
    Am J Obstet Gynecol; 2003 Nov; 189(5):1283-6. PubMed ID: 14634554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome.
    Liguori G; Tolino A; Moccia G; Scognamiglio G; Nappi C
    Gynecol Endocrinol; 1996 Aug; 10(4):257-64. PubMed ID: 8908526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ovulation number in mammals. A follicle interaction law that controls maturation.
    Lacker HM
    Biophys J; 1981 Aug; 35(2):433-54. PubMed ID: 6791721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polycystic ovary syndrome (author's transl)].
    Lecomte P; Kuttenn F; Mauvais-Jarvis P
    Nouv Presse Med; 1978 Feb; 7(5):355-6, 361-2. PubMed ID: 345233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
    Fauser BC; Donderwinkel P; Schoot DC
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transvaginal Ultrasonographic Rates of Folliculogenesis Among Oligomenorrheic Women with Polycystic Ovary Syndrome.
    Dahan MH; Drubach NC; Milki AA
    J Reprod Med; 2016 Sep; 61(9-10):431-435. PubMed ID: 30383940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.